Our results show that ACSL4 preferentially stimulates proliferation in CRC cells (Fig. 1A) and this is associated to a more glycolytic phenotype compared to control or ACSL1 cells, without major changes in mitochondrial performance (Fig. 2A, 2B and 2C). This evidence concerns the gene ACSL4 and colorectal carcinoma.